1. Home
  2. DERM vs SNCR Comparison

DERM vs SNCR Comparison

Compare DERM & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • SNCR
  • Stock Information
  • Founded
  • DERM 2014
  • SNCR 2000
  • Country
  • DERM United States
  • SNCR United States
  • Employees
  • DERM N/A
  • SNCR N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • SNCR EDP Services
  • Sector
  • DERM Health Care
  • SNCR Technology
  • Exchange
  • DERM Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • DERM 116.8M
  • SNCR 101.2M
  • IPO Year
  • DERM 2021
  • SNCR 2006
  • Fundamental
  • Price
  • DERM $4.68
  • SNCR $9.36
  • Analyst Decision
  • DERM Strong Buy
  • SNCR Strong Buy
  • Analyst Count
  • DERM 3
  • SNCR 1
  • Target Price
  • DERM $9.50
  • SNCR $13.00
  • AVG Volume (30 Days)
  • DERM 109.1K
  • SNCR 61.0K
  • Earning Date
  • DERM 11-12-2024
  • SNCR 11-12-2024
  • Dividend Yield
  • DERM N/A
  • SNCR N/A
  • EPS Growth
  • DERM N/A
  • SNCR N/A
  • EPS
  • DERM N/A
  • SNCR N/A
  • Revenue
  • DERM $57,771,000.00
  • SNCR $170,789,000.00
  • Revenue This Year
  • DERM N/A
  • SNCR $7.76
  • Revenue Next Year
  • DERM $36.49
  • SNCR $4.55
  • P/E Ratio
  • DERM N/A
  • SNCR N/A
  • Revenue Growth
  • DERM N/A
  • SNCR 61.81
  • 52 Week Low
  • DERM $2.85
  • SNCR $5.18
  • 52 Week High
  • DERM $8.10
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • DERM 35.33
  • SNCR 43.00
  • Support Level
  • DERM $4.88
  • SNCR $8.50
  • Resistance Level
  • DERM $5.19
  • SNCR $10.80
  • Average True Range (ATR)
  • DERM 0.29
  • SNCR 0.63
  • MACD
  • DERM -0.07
  • SNCR -0.04
  • Stochastic Oscillator
  • DERM 10.94
  • SNCR 37.39

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: